• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测万古霉素治疗。

Monitoring vancomycin therapy.

作者信息

Rybak M J, Boike S C

出版信息

Drug Intell Clin Pharm. 1986 Oct;20(10):757-61. doi: 10.1177/106002808602001003.

DOI:10.1177/106002808602001003
PMID:3769763
Abstract

Vancomycin is an effective and widely used antistaphylococcal antibiotic. Despite several decades of use, however, our knowledge of the toxicologic and pharmacokinetic properties of vancomycin remains incomplete. This review summarizes current information regarding the adverse reactions and pharmacokinetics of vancomycin. Although there have been reports of side effects with vancomycin, these effects tend to be infrequent, easily managed, and reversible. Several methods for adjustment of vancomycin therapy have been recommended. The relationship between serum concentrations of vancomycin and the occurrence of ototoxicity or nephrotoxicity has not been well established. However, because of large interpatient variations in pharmacokinetic parameters, it seems preferable to individualize vancomycin therapy based on serum concentration data.

摘要

万古霉素是一种有效且广泛使用的抗葡萄球菌抗生素。然而,尽管已使用了数十年,但我们对万古霉素的毒理学和药代动力学特性的了解仍不完整。本综述总结了有关万古霉素不良反应和药代动力学的当前信息。尽管有万古霉素副作用的报道,但这些效应往往不常见、易于处理且可逆。已推荐了几种调整万古霉素治疗的方法。万古霉素血清浓度与耳毒性或肾毒性发生之间的关系尚未明确确立。然而,由于患者间药代动力学参数差异很大,基于血清浓度数据对万古霉素治疗进行个体化似乎更为可取。

相似文献

1
Monitoring vancomycin therapy.监测万古霉素治疗。
Drug Intell Clin Pharm. 1986 Oct;20(10):757-61. doi: 10.1177/106002808602001003.
2
Vancomycin: pharmacokinetics and administration regimens in neonates.万古霉素:新生儿的药代动力学及给药方案
Clin Pharmacokinet. 2004;43(7):417-40. doi: 10.2165/00003088-200443070-00001.
3
Pharmacokinetics of vancomycin.万古霉素的药代动力学。
J Antimicrob Chemother. 1984 Dec;14 Suppl D:43-52. doi: 10.1093/jac/14.suppl_d.43.
4
Vancomycin: an update.万古霉素:最新进展。
Pharmacotherapy. 1986 Jul-Aug;6(4):153-69. doi: 10.1002/j.1875-9114.1986.tb03471.x.
5
Vancomycin ototoxicity and nephrotoxicity. A review.万古霉素的耳毒性和肾毒性。综述。
Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):376-86. doi: 10.1007/BF03259891.
6
Vancomycin pharmacokinetics in premature infants.
Pediatr Pharmacol (New York). 1985;5(1):17-22.
7
Vancomycin pharmacokinetics in small, seriously ill infants.
Am J Dis Child. 1986 Feb;140(2):107-10. doi: 10.1001/archpedi.1986.02140160025021.
8
[Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].[腹腔内给药后持续非卧床腹膜透析(CAPD)慢性肾衰竭患者万古霉素的药代动力学]
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):542-4.
9
Vancomycin.万古霉素
Mayo Clin Proc. 1983 Feb;58(2):88-91.
10
[Vancomycin intoxication in a patient with inappropriate antidiuretic hormone syndrome and diarrhea].[一名患有抗利尿激素分泌不当综合征及腹泻患者的万古霉素中毒]
Farm Hosp. 2015 Jul 1;39(4):219-21. doi: 10.7399/fh.2015.39.4.8095.

引用本文的文献

1
Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.两种使用首剂后估算曲线下面积优化万古霉素给药剂量的创新方法:利用群体药代动力学模型结合蒙特卡洛模拟生成的数据进行验证,并与一级药代动力学方程方法进行比较。
Pharmaceutics. 2022 May 7;14(5):1004. doi: 10.3390/pharmaceutics14051004.
2
Vancomycin monitoring in children using bayesian estimation.使用贝叶斯估计法对儿童进行万古霉素监测。
Ther Drug Monit. 2014 Aug;36(4):510-8. doi: 10.1097/FTD.0000000000000039.
3
Vancomycin utilization evaluation at hematology-oncology ward of a teaching hospital in iran.
伊朗一家教学医院血液肿瘤科万古霉素使用情况评估
Iran J Pharm Res. 2012 Winter;11(1):163-70.
4
The serum vancomycin assay: A test of historic interest.血清万古霉素检测:一项具有历史意义的检测。
Can J Infect Dis. 1995 Mar;6(2):67-8. doi: 10.1155/1995/154760.
5
Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function.利用血清胱抑素 C 作为肾功能标志物的万古霉素群体药代动力学分析。
Antimicrob Agents Chemother. 2010 Feb;54(2):778-82. doi: 10.1128/AAC.00661-09. Epub 2009 Nov 23.
6
Cost-ineffectiveness of serum vancomycin levels.血清万古霉素水平的成本效益不佳。
Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):509-11. doi: 10.1007/s10096-007-0314-4.
7
Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.万古霉素在重症监护病房患者中的药代动力学/药效学分析。
Intensive Care Med. 2007 Feb;33(2):279-85. doi: 10.1007/s00134-006-0470-5. Epub 2006 Dec 13.
8
Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.血液系统恶性肿瘤患者万古霉素的群体药代动力学分析。
Antimicrob Agents Chemother. 2005 Dec;49(12):4934-41. doi: 10.1128/AAC.49.12.4934-4941.2005.
9
Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers.正常志愿者中两种万古霉素给药方案的稳态药代动力学比较。
Antimicrob Agents Chemother. 1987 Mar;31(3):393-7. doi: 10.1128/AAC.31.3.393.
10
Teicoplanin in perspective. A critical comparison with vancomycin.
Pharm Weekbl Sci. 1991 Aug 23;13(4):153-60. doi: 10.1007/BF01957739.